Free Trial

LakeShore Biopharma (LSB) Competitors

LakeShore Biopharma logo
$0.83 +0.03 (+3.25%)
As of 04:00 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

LSB vs. RPTX, IVVD, GANX, INKT, COEP, MNOV, GNTA, ADVM, CUE, and ALGS

Should you be buying LakeShore Biopharma stock or one of its competitors? The main competitors of LakeShore Biopharma include Repare Therapeutics (RPTX), Invivyd (IVVD), Gain Therapeutics (GANX), MiNK Therapeutics (INKT), Coeptis Therapeutics (COEP), MediciNova (MNOV), Genenta Science (GNTA), Adverum Biotechnologies (ADVM), Cue Biopharma (CUE), and Aligos Therapeutics (ALGS). These companies are all part of the "pharmaceutical products" industry.

LakeShore Biopharma vs. Its Competitors

Repare Therapeutics (NASDAQ:RPTX) and LakeShore Biopharma (NASDAQ:LSB) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, valuation, risk, analyst recommendations, profitability, institutional ownership, dividends and earnings.

LakeShore Biopharma's return on equity of 0.00% beat Repare Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Repare TherapeuticsN/A -78.25% -66.85%
LakeShore Biopharma N/A N/A N/A

85.1% of Repare Therapeutics shares are owned by institutional investors. Comparatively, 52.6% of LakeShore Biopharma shares are owned by institutional investors. 11.5% of Repare Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Repare Therapeutics has a beta of 0.93, meaning that its share price is 7% less volatile than the S&P 500. Comparatively, LakeShore Biopharma has a beta of 0.56, meaning that its share price is 44% less volatile than the S&P 500.

LakeShore Biopharma has higher revenue and earnings than Repare Therapeutics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Repare Therapeutics$250K286.97-$84.69M-$2.58-0.65
LakeShore Biopharma$614.96M0.03-$13.93MN/AN/A

In the previous week, LakeShore Biopharma had 2 more articles in the media than Repare Therapeutics. MarketBeat recorded 3 mentions for LakeShore Biopharma and 1 mentions for Repare Therapeutics. Repare Therapeutics' average media sentiment score of 1.88 beat LakeShore Biopharma's score of 0.90 indicating that Repare Therapeutics is being referred to more favorably in the media.

Company Overall Sentiment
Repare Therapeutics Very Positive
LakeShore Biopharma Positive

Repare Therapeutics presently has a consensus target price of $4.50, indicating a potential upside of 169.46%. Given Repare Therapeutics' stronger consensus rating and higher possible upside, equities research analysts plainly believe Repare Therapeutics is more favorable than LakeShore Biopharma.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Repare Therapeutics
0 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.50
LakeShore Biopharma
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Summary

Repare Therapeutics beats LakeShore Biopharma on 8 of the 13 factors compared between the two stocks.

Get LakeShore Biopharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for LSB and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding LSB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LSB vs. The Competition

MetricLakeShore BiopharmaMED IndustryMedical SectorNASDAQ Exchange
Market Cap$17.15M$3.08B$5.76B$9.75B
Dividend YieldN/A2.26%3.95%4.02%
P/E RatioN/A20.9231.4526.39
Price / Sales0.03355.43431.57159.28
Price / CashN/A44.7137.7559.42
Price / Book0.258.0410.566.59
Net Income-$13.93M-$53.98M$3.27B$265.83M
7 Day Performance-0.36%-0.89%0.60%0.18%
1 Month Performance-8.27%5.66%5.42%2.13%
1 Year Performance-81.32%9.06%50.36%21.07%

LakeShore Biopharma Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LSB
LakeShore Biopharma
1.1611 of 5 stars
$0.83
+3.3%
N/A-81.9%$17.15M$614.96M0.00773News Coverage
RPTX
Repare Therapeutics
2.8239 of 5 stars
$1.61
+1.9%
$4.50
+179.5%
-45.0%$67.88M$53.48M-0.62180Positive News
High Trading Volume
IVVD
Invivyd
4.0365 of 5 stars
$1.03
+84.0%
$3.18
+209.1%
+10.0%$67.24M$46.21M-1.12100Analyst Forecast
Gap Up
High Trading Volume
GANX
Gain Therapeutics
2.1696 of 5 stars
$1.92
+4.3%
$7.80
+306.3%
+41.4%$66.14M$50K-3.0520News Coverage
Analyst Revision
INKT
MiNK Therapeutics
2.736 of 5 stars
$15.15
+4.0%
$37.50
+147.5%
+86.4%$65.90MN/A-5.2630
COEP
Coeptis Therapeutics
0.657 of 5 stars
$13.21
-3.2%
N/A+225.3%$65.82M$263.56K-2.282News Coverage
Positive News
Gap Up
MNOV
MediciNova
2.2091 of 5 stars
$1.36
+3.0%
$7.00
+414.7%
-2.2%$64.74M$1M-5.4410Analyst Forecast
Gap Up
GNTA
Genenta Science
2.3356 of 5 stars
$3.52
+0.9%
$25.00
+610.2%
-6.1%$63.83MN/A0.007News Coverage
Gap Up
ADVM
Adverum Biotechnologies
4.1306 of 5 stars
$3.16
+4.3%
$19.75
+525.0%
-56.2%$63.48M$1M-0.40190
CUE
Cue Biopharma
2.5569 of 5 stars
$0.84
+2.7%
N/A+14.5%$62.88M$9.29M-1.5060
ALGS
Aligos Therapeutics
4.425 of 5 stars
$10.98
+7.5%
$50.00
+355.4%
-15.2%$62.81M$3.94M-0.5590Positive News

Related Companies and Tools


This page (NASDAQ:LSB) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners